Clinical Trial Update: Immunogenicity & Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine With Different Adjuvants [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating immunogenicity and reactogenicity of multiple formulations of recombinant hepatitis B vaccine with different adjuvants. The study has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Engerix-B (hepatitis B vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 2 | Status: COMPLETED